Niranjan Kameswaran | Vice President, Strategy |
Mary Reumuth | Chief Financial Officer |
Mark Iwicki | Chairman, President & Chief Executive Officer |
Kim Brazzell | Chief Medical Officer |
Todd Bazemore | Chief Operating Officer |
Chris Neyor | JPMorgan |
Kambiz Yazdi | Wedbush Securities |
Faizzan Ahmad | H.C. Wainwright |
Good morning and welcome to Kala Pharmaceuticals' Third Quarter 2019 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Following management's prepared remarks, a Q&A session will be held.
As a reminder, this call is being recorded.
I would now like to turn the call over to Niranjan Kameswaran, Vice President of Strategy for Kala Pharmaceuticals.